{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T07:35:59Z","timestamp":1774424159732,"version":"3.50.1"},"reference-count":22,"publisher":"American Association of Psychiatric Pharmacists (AAPP)","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n        <jats:sec>\n          <jats:title>Introduction<\/jats:title>\n          <jats:p>Transgender and nonbinary (TGNB) individuals are highly stigmatized members of society and are significantly at higher risk of having mood or anxiety-related disorders compared to non-TGNB individuals.<\/jats:p>\n        <\/jats:sec>\n        <jats:sec>\n          <jats:title>Methods<\/jats:title>\n          <jats:p>In this retrospective cohort study, antidepressant prescribing data were collected from TGNB adults diagnosed with gender dysphoria (GD) and mood or anxiety-related disorder between January 2005 and October 2021. The primary outcome was to compare the number of active outpatient antidepressant prescriptions at the time of GD diagnosis between gender identities. The secondary outcomes were to compare antidepressant class utilization between gender identities as well as the prevalence of concurrent mood or anxiety-related disorder diagnoses between gender identities.<\/jats:p>\n        <\/jats:sec>\n        <jats:sec>\n          <jats:title>Results<\/jats:title>\n          <jats:p>Of 131 patients who met inclusion criteria, there was no significant difference in number of active antidepressant prescriptions between gender identities at the time of the GD diagnosis (<jats:italic>p<\/jats:italic>\u2009=\u2009.357). However, transgender females were prescribed bupropion at significantly higher rates than other gender identities (<jats:italic>p<\/jats:italic>\u2009=\u2009.046). Approximately 38% of patients did not have an active antidepressant prescription at the time of GD diagnosis despite concurrent mood or anxiety-related diagnoses. The prevalence of generalized anxiety disorder was significantly greater among transgender males (<jats:italic>p<\/jats:italic>\u2009=\u2009.044).<\/jats:p>\n        <\/jats:sec>\n        <jats:sec>\n          <jats:title>Discussion<\/jats:title>\n          <jats:p>Although the number of active antidepressant prescriptions between gender identities were similar in this study, we found 38% of patients were not prescribed any antidepressants at time of GD and mood or anxiety-related disorders. This serendipitous finding elucidates a potential gap in mental health care among transgender adults.<\/jats:p>\n        <\/jats:sec>","DOI":"10.9740\/mhc.2023.12.298","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T14:58:42Z","timestamp":1701442722000},"page":"298-302","source":"Crossref","is-referenced-by-count":2,"title":["Antidepressant prescribing in transgender and nonbinary individuals diagnosed with gender dysphoria and mood or anxiety disorders"],"prefix":"10.9740","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2417-0528","authenticated-orcid":true,"given":"Casey M.","family":"Tiefenthaler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1674-4210","authenticated-orcid":true,"given":"Kelly C.","family":"Lee","sequence":"additional","affiliation":[{"name":"Clinical Psychiatric Pharmacy Specialist, University of California, San Diego Health, San Diego, California; University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4719","reference":[{"key":"i2168-9709-13-6-298-b01","article-title":"Who\/Europe brief \u2013 transgender health in the context of ICD-11 [cited 2023 Mar 30]","year":"2021","unstructured":"Who\/Europe brief \u2013 transgender health in the context of ICD-11 [cited 2023 Mar 30].\nWorld Health Organization;\n2021\n.\nAvailable from: https:\/\/www.euro.who.int\/en\/health-topics\/health-determinants\/gender\/gender-definitions\/whoNATAeurope-brief-transgender-health-in-the-context-of-icd-11"},{"key":"i2168-9709-13-6-298-b02","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association\n          .\nDiagnostic and statistical manual of mental disorders. 5th ed.Association;\n2013\n."},{"issue":"(1)","key":"i2168-9709-13-6-298-b03","series-title":"J Health Soc Behav","first-page":"72","article-title":"Demographics and LGBT health","volume":"54","author":"Gates","year":"2013","unstructured":"Gates\n              GJ.\n            \n          \n          Demographics and LGBT health.\nJ Health Soc Behav.\n2013;\n54(1):\n72\u20134.\nDOI: 10.1177\/0022146512474429"},{"key":"i2168-9709-13-6-298-b04","article-title":"How many adults identify as transgender in the United States","author":"Flores","year":"2016","unstructured":"Flores\n              AR\n            ,\nHermanJL,\nGatesGJ,\nBrownTNT.\n          How many adults identify as transgender in the United States\n          2016\n          [cited 2023 Mar 28].\nAvailable from: https:\/\/williamsinstitute.law.ucla.edu\/wp-content\/uploads\/Trans-Adults-US-Aug-2016.pdf"},{"issue":"(4)","key":"i2168-9709-13-6-298-b05","series-title":"J Sex Medicine","first-page":"582","article-title":"The Amsterdam Cohort of Gender Dysphoria Study (1972\u20132015): trends in prevalence, treatment, and regrets","volume":"15","author":"Wiepjes","year":"2018","unstructured":"Wiepjes\n              CM\n            ,\nNotaNM,\nde BlokCJM,\nKlaverM,\nde VriesALC,\nWensing-KrugerSA,\net al.\n          The Amsterdam Cohort of Gender Dysphoria Study (1972\u20132015): trends in prevalence, treatment, and regrets.\nJ Sex Medicine.\n2018;\n15(4):\n582\u201390.\nDOI: 10.1016\/j.jsxm.2018.01.016"},{"issue":"(4)","key":"i2168-9709-13-6-298-b06","series-title":"Soc Sci Medicine","first-page":"222","article-title":"Transgender stigma and health: a critical review of stigma determinants, mechanisms, and interventions","volume":"147","author":"White Hughto","year":"2015","unstructured":"White Hughto\n              JM\n            ,\nReisnerSL,\nPachankisJE.\n          Transgender stigma and health: a critical review of stigma determinants, mechanisms, and interventions.\nSoc Sci Medicine.\n2015;\n147(4):\n222\u201331.\nDOI: 10.1016\/j.socscimed.2015.11.010"},{"issue":"(1)","key":"i2168-9709-13-6-298-b07","series-title":"Transgender Health","first-page":"313","article-title":"Mental health diagnoses among transgender patients in the clinical setting: an all-payer electronic health record study","volume":"4","author":"Wanta","year":"2019","unstructured":"Wanta\n              JW\n            ,\nNiforatosJD,\nDurbakE,\nVigueraA,\nAltinayM.\n          Mental health diagnoses among transgender patients in the clinical setting: an all-payer electronic health record study.\nTransgender Health.\n2019;\n4(1):\n313\u20135.\nDOI: 10.1089\/trgh.2019.0029"},{"key":"i2168-9709-13-6-298-b08","author":"James","year":"2016","unstructured":"James\n              SE\n            ,\nHermanJL,\nRankinS,\nKeislingM,\nMottetL,\nAnafiM. The report of the 2015 US Transgender Survey.\nNational Center for Transgender Equality;\n2016\n."},{"issue":"(12)","key":"i2168-9709-13-6-298-b09","series-title":"Curr Psychiatry Rep","article-title":"Gender-affirming hormone use in transgender individuals: impact on behavioral health and cognition","volume":"20","author":"Nguyen","year":"2018","unstructured":"Nguyen\n              HB\n            ,\nChavezAM,\nLipnerE,\nHantsooL,\nKornfieldSL,\nDaviesRD,\net al.\n          Gender-affirming hormone use in transgender individuals: impact on behavioral health and cognition.\nCurr Psychiatry Rep.\n2018;\n20(12)DOI: 10.1007\/s11920-018-0973-0"},{"issue":"(Supplement_4)","key":"i2168-9709-13-6-298-b10","series-title":"European J Public Health","article-title":"Reduction in mental health treatment utilization among transgender individuals after gender-affirming surgeries: a total population study","volume":"29","author":"Br\u00e4nstr\u00f6m","year":"2019","unstructured":"Br\u00e4nstr\u00f6m\n              R\n            ,\nPachankisJE.\n          Reduction in mental health treatment utilization among transgender individuals after gender-affirming surgeries: a total population study.\nEuropean J Public Health.\n2019;\n29(Supplement_4)DOI: 10.1093\/eurpub\/ckz185.465"},{"issue":"(sup1)","key":"i2168-9709-13-6-298-b11","series-title":"Int J Transgender Health","first-page":"S1","article-title":"Standards of care for the health of transgender and gender diverse people, version 8","volume":"23","author":"Coleman","year":"2022","unstructured":"Coleman\n              E\n            ,\nRadixAE,\nBoumanWP,\nBrownGR,\nde VriesALC,\nDeutschMB,\net al.\n          Standards of care for the health of transgender and gender diverse people, version 8.\nInt J Transgender Health.\n3rd ed.2022;\n23(sup1):\nS1\u2013259.\nDOI: 10.1080\/26895269.2022.2100644"},{"issue":"(8)","key":"i2168-9709-13-6-298-b12","series-title":"Plastic Reconstr Surg Global Open","first-page":"e3008","article-title":"Barriers to gender-affirming surgery consultations in a sample of transmasculine patients in Boston, Mass","volume":"8","author":"Tabaac","year":"2020","unstructured":"Tabaac\n              AR\n            ,\nJollyD,\nBoskeyER,\nGanorO.\n          Barriers to gender-affirming surgery consultations in a sample of transmasculine patients in Boston, Mass.\nPlastic Reconstr Surg Global Open.\n2020;\n8(8):\ne3008.\nDOI: 10.1097\/GOX.0000000000003008"},{"key":"i2168-9709-13-6-298-b13","series-title":"Front. Psychiatry","article-title":"National prescription patterns of antidepressants in the treatment of adults with major depression in the US between 1996 and 2015: a population representative survey based analysis","volume":"11","author":"Luo","year":"2020","unstructured":"Luo\n              Y\n            ,\nKataokaY,\nOstinelliEG,\nCiprianiA,\nFurukawaTA.\n          National prescription patterns of antidepressants in the treatment of adults with major depression in the US between 1996 and 2015: a population representative survey based analysis.\nFront. Psychiatry.\n2020;\n11.\nDOI: 10.3389\/fpsyt.2020.00035"},{"issue":"(12)","key":"i2168-9709-13-6-298-b14","series-title":"N Engl J Med","first-page":"1243","article-title":"Medication augmentation after the failure of SSRIs for depression","volume":"354","author":"Trivedi","year":"2006","unstructured":"Trivedi\n              MH\n            ,\nFavaM,\nWisniewskiSR,\nThaseME,\nQuitkinF,\nWardenD,\net al.\n          Medication augmentation after the failure of SSRIs for depression.\nN Engl J Med.\n2006;\n354(12):\n1243\u201352.\nDOI: 10.1056\/NEJMoa052964"},{"key":"i2168-9709-13-6-298-b15","article-title":"WELLBUTRIN (buproprion hydrochloride) tablet. Published 2007 [rev. 2022 Mar]","author":"Solco Healthcare US LLC.","unstructured":"Solco Healthcare US LLC.\n          \n          WELLBUTRIN (buproprion hydrochloride) tablet. Published 2007 [rev. 2022 Mar]. In:\nDailyMed [Internet, cited 2023 Mar 30]. Available from: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=39b2d509-1281-4464-9cf1-a94bbc18b84b"},{"issue":"(10)","key":"i2168-9709-13-6-298-b16","series-title":"J Clin Psychiatry","first-page":"1606","article-title":"Gender differences in generalized anxiety disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)","volume":"69","author":"Vesga-L\u00f3pez","year":"2008","unstructured":"Vesga-L\u00f3pez\n              O\n            ,\nSchneierFR,\nWangS,\nHeimbergRG,\nLiuSM,\nHasinDS,\net al.\n          Gender differences in generalized anxiety disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).\nJ Clin Psychiatry.\n2008Oct;69(10):\n1606\u201316."},{"issue":"(8)","key":"i2168-9709-13-6-298-b17","series-title":"J Psychiatric Res","first-page":"1027","article-title":"Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness","volume":"45","author":"McLean","year":"2011","unstructured":"McLean\n              CP\n            ,\nAsnaaniA,\nLitzBT,\nHofmannSG.\n          Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness.\nJ Psychiatric Res.\n2011;\n45(8):\n1027\u201335.\nDOI: 10.1016\/j.jpsychires.2011.03.006"},{"issue":"(7)","key":"i2168-9709-13-6-298-b18","series-title":"Arch Sex Behav","first-page":"1983","article-title":"Adolescents with gender dysphoria: reflections on some contemporary clinical and research issues","volume":"48","author":"Zucker","year":"2019","unstructured":"Zucker\n              KJ.\n            \n          \n          Adolescents with gender dysphoria: reflections on some contemporary clinical and research issues.\nArch Sex Behav.\n2019;\n48(7):\n1983\u201392.\nDOI: 10.1007\/s10508-019-01518-8"},{"issue":"(5)","key":"i2168-9709-13-6-298-b19","series-title":"Horm Res Paediatr","first-page":"326","article-title":"ESPE and PES international survey of centers and clinicians delivering specialist care for children and adolescents with gender dysphoria","volume":"90","author":"Skordis","year":"2018","unstructured":"Skordis\n              N\n            ,\nButlerG,\nde VriesMC,\nMainK,\nHannemaSE.\n          ESPE and PES international survey of centers and clinicians delivering specialist care for children and adolescents with gender dysphoria.\nHorm Res Paediatr.\n2018;\n90(5):\n326\u201331.\nDOI: 10.1159\/000496115"},{"issue":"(5)","key":"i2168-9709-13-6-298-b20","series-title":"Bjpsych Bull","first-page":"206","article-title":"Individuals seeking gender reassignment: marked increase in demand for services","volume":"42","author":"Fielding","year":"2018","unstructured":"Fielding\n              J\n            ,\nBassC.\n          Individuals seeking gender reassignment: marked increase in demand for services.\nBjpsych Bull.\n2018;\n42(5):\n206\u201310.\nDOI: 10.1192\/bjb.2018.30"},{"issue":"(4)","key":"i2168-9709-13-6-298-b21","series-title":"Lgbt Health","first-page":"287","article-title":"The time is now: attention increases to transgender health in the United States but scientific knowledge gaps remain","volume":"2","author":"MacCarthy","year":"2015","unstructured":"MacCarthy\n              S\n            ,\nReisnerSL,\nNunnA,\nPerez-BrumerA,\nOperarioD.\n          The time is now: attention increases to transgender health in the United States but scientific knowledge gaps remain.\nLgbt Health.\n2015;\n2(4):\n287\u201391.\nDOI: 10.1089\/lgbt.2014.0073"},{"key":"i2168-9709-13-6-298-b22","series-title":"Front. Genet","article-title":"Genetic and epigenetic consequence of early-life social stress on depression: role of serotonin-associated genes","volume":"11","author":"Soga","year":"2021","unstructured":"Soga\n              T\n            ,\nTeoCH,\nParharI.\n          Genetic and epigenetic consequence of early-life social stress on depression: role of serotonin-associated genes.\nFront. Genet.\n2021;\n11.\nDOI: 10.3389\/fgene.2020.601868"}],"container-title":["Mental Health Clinician"],"original-title":[],"link":[{"URL":"https:\/\/mhc.kglmeridian.com\/view\/journals\/mhcl\/13\/6\/article-p298.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/meridian.allenpress.com\/mhc\/article-pdf\/13\/6\/298\/3296169\/i2168-9709-13-6-298.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/mhc.kglmeridian.com\/downloadpdf\/journals\/mhcl\/13\/6\/article-p298.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/mhc.kglmeridian.com\/downloadpdf\/journals\/mhcl\/13\/6\/article-p298.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:32:26Z","timestamp":1732062746000},"score":1,"resource":{"primary":{"URL":"https:\/\/mhc.kglmeridian.com\/view\/journals\/mhcl\/13\/6\/article-p298.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":22,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.9740\/mhc.2023.12.298","relation":{},"ISSN":["2168-9709"],"issn-type":[{"value":"2168-9709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]}}}